video corpo

Evolut™ PRO+
12Pages

{{requestButtons}}

Catalog excerpts

Evolut™ PRO+ - 1

Transcatheter Aortic Valve System

Open the catalog to page 1
Evolut™ PRO+ - 2

From a design built on a proven platform, the Evolut PRO system is taking valve performance and patient outcomes above and beyond. HEMODYNAMIC PERFORMANCE for exceptional patient outcomes ADVANCED SEALING for all valve sizes and across the broadest annular range† † LOWEST DELIVERY PROFILE for access down to 5.0 mm vessels with the 23-29 mm valve

Open the catalog to page 2
Evolut™ PRO+ - 3

From a design built on a proven platform, the Evolut PRO system is taking valve performance and patient outcomes above and beyond. HEMODYNAMIC PERFORMANCE for exceptional patient outcomes ADVANCED SEALING for all valve sizes and across the broadest annular range† † LOWEST DELIVERY PROFILE for access down to 5.0 mm vessels with the 23-29 mm valve

Open the catalog to page 3
Evolut™ PRO+ - 4

THE EVOLUT ™ HEMODYNAMIC ADVANTAGE Evolut TAVR has demonstrated large effective orifice areas (EOAs), thereby: Superiority vs. SAVR The Evolut TAV’s supra-annular, selfexpanding valve design delivers exceptional hemodynamics and is the only TAVR device to demonstrate hemodynamic superiority in a low-risk clinical trial vs. SAVR.1 Evolut TAVR 2.3 cm² vs. SAVR 2.0 cm2 Evolut TAVR 8.6 mm Hg vs. SAVR 11.2 mm Hg LARGER EOAs LOWER GRADIENTS Lowering risk of severe patientprosthesis mismatch (PPM) and subsequently reducing risk of mortality and heart failure rehospitalizations2; Promoting...

Open the catalog to page 4
Evolut™ PRO+ - 5

THE EVOLUT ™ HEMODYNAMIC ADVANTAGE Evolut TAVR has demonstrated large effective orifice areas (EOAs), thereby: Superiority vs. SAVR The Evolut TAV’s supra-annular, selfexpanding valve design delivers exceptional hemodynamics and is the only TAVR device to demonstrate hemodynamic superiority in a low-risk clinical trial vs. SAVR.1 Evolut TAVR 2.3 cm² vs. SAVR 2.0 cm2 Evolut TAVR 8.6 mm Hg vs. SAVR 11.2 mm Hg LARGER EOAs LOWER GRADIENTS Lowering risk of severe patientprosthesis mismatch (PPM) and subsequently reducing risk of mortality and heart failure rehospitalizations2; Promoting...

Open the catalog to page 5
Evolut™ PRO+ - 6

LEADERSHIP IN VALVE DESIGN The external tissue wrap on the Evolut PRO valves has shown excellent PVL performance.6 With the addition of the wrap to the 34 mm PRO valve, similar results can be expected — offering advanced sealing across the platform. Total Aortic Regurgitation at 30 Days6 100% Percentage of Available Echos (%) Advanced Sealing across the Platform Low Rates of Moderate/Severe PVL Real-world commercial experience from the STS/ ACC TVT Registry™* demonstrates excellent PVL performance. Moderate Mild None/Trace Severe The views or opinions presented in this document are solely...

Open the catalog to page 6
Evolut™ PRO+ - 7

LEADERSHIP IN VALVE DESIGN The external tissue wrap on the Evolut PRO valves has shown excellent PVL performance.6 With the addition of the wrap to the 34 mm PRO valve, similar results can be expected — offering advanced sealing across the platform. Total Aortic Regurgitation at 30 Days6 100% Percentage of Available Echos (%) Advanced Sealing across the Platform Low Rates of Moderate/Severe PVL Real-world commercial experience from the STS/ ACC TVT Registry™* demonstrates excellent PVL performance. Moderate Mild None/Trace Severe The views or opinions presented in this document are solely...

Open the catalog to page 7
Evolut™ PRO+ - 8

TREAT MORE PATIENTS Broadening Access with an Expanded Platform and Expanded Indication § With a reduced delivery profile for 23-29 mm valves, only Medtronic is indicated to treat patients with vessels as small as 5.0 mm. § With the ability to treat the broadest annulus range† of any commercially available TAVR system, Evolut PRO valves can treat annulus ranges from 17**/18 mm to 30 mm. § The Evolut PRO system is approved for all symptomatic severe aortic stenosis patients. By CT measurement. Measurement is for TAV-in-SAV only.

Open the catalog to page 8
Evolut™ PRO+ - 9

TREAT MORE PATIENTS Broadening Access with an Expanded Platform and Expanded Indication § With a reduced delivery profile for 23-29 mm valves, only Medtronic is indicated to treat patients with vessels as small as 5.0 mm. § With the ability to treat the broadest annulus range† of any commercially available TAVR system, Evolut PRO valves can treat annulus ranges from 17**/18 mm to 30 mm. § The Evolut PRO system is approved for all symptomatic severe aortic stenosis patients. By CT measurement. Measurement is for TAV-in-SAV only.

Open the catalog to page 9
Evolut™ PRO+ - 10

Purposeful design to provide you with the performance and outcomes you need to help patients live life to the fullest.

Open the catalog to page 10
Evolut™ PRO+ - 11

Purposeful design to provide you with the performance and outcomes you need to help patients live life to the fullest.

Open the catalog to page 11
Evolut™ PRO+ - 12

References 1 Popma JJ, Deeb GM, Yakubov SJ, et al. Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients. N Engl J Med. May 2, 2019;380(18):1706-1715. 2 H errmann HC, Daneshvar SA, Fonarow GC, et al. Prosthesis-Patient Mismatch in 62,125 Patients Following Transcatheter Aortic Valve Replacement: From the STS/ACC TVT Registry. J Am Coll Cardiol. December 4, 2018;72(22):2701-2711. 3 B leiziffer S, Eichinger WB, Hettich I, et al. Impact of patient-prosthesis mismatch on exercise capacity in patients after bioprosthetic aortic valve replacement. Heart. May...

Open the catalog to page 12

All Medtronic catalogs and technical brochures

  1. EverFlex™

    4 Pages

  2. Micra™

    12 Pages

  3. Provia™

    4 Pages

  4. Intuition™

    3 Pages

  5. 5392

    2 Pages

  6. SOLOIST™

    2 Pages

  7. BIS

    16 Pages

Archived catalogs

  1. MicroFrance®

    166 Pages

  2. HMS Plus

    6 Pages

  3. Endurant II

    8 Pages

  4. StealthViz

    4 Pages

  5. ENT product

    476 Pages

  6. Parts catalog

    15 Pages